ZARXIO Trademark

Trademark Overview

On Friday, April 4, 2014, a trademark application was filed for ZARXIO with the United States Patent and Trademark Office. The USPTO has given the ZARXIO trademark a serial number of 86242357. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Friday, June 10, 2022. This trademark is owned by Novartis AG. The ZARXIO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for use in stimulating white blood cell production available only by prescription
zarxio

General Information

Serial Number86242357
Word MarkZARXIO
Filing DateFriday, April 4, 2014
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateFriday, June 10, 2022
Registration Number4886448
Registration DateTuesday, January 12, 2016
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, November 4, 2014

Trademark Statements

Description of MarkThe mark consists of three overlapping small, medium and large teardrops followed by the word ZARXIO.
Goods and ServicesPharmaceutical preparations for use in stimulating white blood cell production available only by prescription
Indication of Colors claimedThe color(s) blue, light gray, dark gray and white is/are claimed as a feature of the mark.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, April 17, 2014
Primary Code005
First Use Anywhere DateThursday, September 3, 2015
First Use In Commerce DateThursday, September 3, 2015

Trademark Owner History

Party NameSANDOZ AG
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressBASEL 4051
CH
Party NameNovartis AG
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBasel 4002
CH
Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBasel
CH
Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBasel
CH

Trademark Events

Event DateEvent Description
Wednesday, December 6, 2023AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Friday, June 10, 2022NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Friday, June 10, 2022REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Friday, June 10, 2022CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, December 21, 2021TEAS SECTION 8 & 15 RECEIVED
Tuesday, January 12, 2021COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, January 12, 2016REGISTERED-PRINCIPAL REGISTER
Tuesday, December 8, 2015NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, December 7, 2015ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, December 4, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, December 4, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, December 4, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, September 21, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, September 21, 2015NON-FINAL ACTION E-MAILED
Monday, September 21, 2015SU - NON-FINAL ACTION - WRITTEN
Saturday, September 12, 2015STATEMENT OF USE PROCESSING COMPLETE
Thursday, September 3, 2015USE AMENDMENT FILED
Saturday, September 12, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, September 3, 2015TEAS STATEMENT OF USE RECEIVED
Tuesday, June 23, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, June 20, 2015SOU EXTENSION 1 GRANTED
Saturday, June 20, 2015SOU EXTENSION 1 FILED
Saturday, June 20, 2015SOU TEAS EXTENSION RECEIVED
Tuesday, December 30, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 4, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 4, 2014PUBLISHED FOR OPPOSITION
Wednesday, October 15, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 30, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, September 26, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, September 25, 2014EXAMINER'S AMENDMENT ENTERED
Thursday, September 25, 2014NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, September 25, 2014EXAMINERS AMENDMENT E-MAILED
Thursday, September 25, 2014EXAMINERS AMENDMENT -WRITTEN
Tuesday, September 16, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, September 15, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, September 15, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, September 5, 2014NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, September 5, 2014NON-FINAL ACTION E-MAILED
Friday, September 5, 2014NON-FINAL ACTION WRITTEN
Friday, August 22, 2014PREVIOUS ALLOWANCE COUNT WITHDRAWN
Tuesday, August 12, 2014WITHDRAWN FROM PUB - OG REVIEW QUERY
Thursday, July 31, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, July 28, 2014ASSIGNED TO LIE
Tuesday, July 15, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, June 24, 2014EXAMINER'S AMENDMENT ENTERED
Tuesday, June 24, 2014NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, June 24, 2014EXAMINERS AMENDMENT E-MAILED
Tuesday, June 24, 2014EXAMINERS AMENDMENT -WRITTEN
Monday, June 16, 2014ASSIGNED TO EXAMINER
Friday, April 18, 2014NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, April 17, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, April 8, 2014NEW APPLICATION ENTERED

Related Keywords

zarxio production available only prescription cell blood preparations stimulating white pharmaceutical